BRIAN FORBUS: Open Payments
NPI 1225103302 · CONWAY, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$572 in 31 payments from 13 companies in 2025. Trend: 2023 $358 · 2024 $500 · 2025 $572
Food & beverage: $572
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $102 |
| Boston Scientific Corporation | 3 | $63 |
| Saluda Medical Americas, Inc. | 3 | $63 |
| PFIZER INC. | 3 | $60 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $54 |
| ABBVIE INC. | 3 | $49 |
| Amgen Inc. | 2 | $48 |
| Exact Sciences Corporation | 2 | $35 |
| Novo Nordisk Inc | 2 | $33 |
| Spinal Simplicity, LLC | 1 | $20 |
Products named: Evoke, TRINTELLIX, ELIQUIS, Cologuard Collection Kit, Ozempic, REPATHA, QULIPTA, General - Therapies.
Industry payments across SC — which companies pay providers there.
